GGenetics Read More A more precise way to edit the genome | MIT NewsSeptember 17, 2025 A genome-editing technique known as prime editing holds potential for treating many diseases by transforming faulty genes into…
GGenetics Read More Genome Editing Market Forecast Report 2025-2030, with Profiles of Merck, Horizon Discovery, GenScript, Sangamo Therapeutics, Danaher, Lonza, BEX, OriGene Technologies, CRISPR Therapeutics, and MoreSeptember 16, 2025 Company Logo Key growth drivers in the genome editing market include rising cancer/genetic disorder cases, increased investments, and…
GGenetics Read More AI enables precise gene editingSeptember 9, 2025 A research team led by the University of Zurich (UZH) has developed a powerful new method to precisely…
GGenetics Read More Sarepta Says Deaths of Two Elevidys Patients Posted on FDA Database Unrelated to TreatmentAugust 11, 2025 Sarepta Therapeutics (NASDAQ: SRPT) said Friday that the deaths of two patients taking its marketed gene therapy Elevidys®…
GGenetics Read More Now Hear This: New Study Compares Gene Therapy and Cochlear ImplantsAugust 7, 2025 By: Staff Writer | August 07, 2025 | 5 min. read | Share Summary Dr. Xue Zhong Liu was…
GGenetics Read More Japan’s Genome Editing Market Set to Reach USD 1.45 Billion by 2033July 30, 2025 Company Logo Japan’s genome editing market, valued at USD 1.45 billion by 2033, grows at a 17.97% CAGR,…